Alpers Huttenlocher Natural History Study
Condition(s):Alpers Huttenlocher SyndromeLast Updated:August 1, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Alpers Huttenlocher SyndromeLast Updated:August 1, 2022Terminated
Condition(s):Acute Disseminated Encephalomyelitis; Devic’s Syndrome; Marburg’s Variant of Multiple Sclerosis; Balo’s Concentric Sclerosis; Acute Transverse MyelitisLast Updated:June 24, 2005Unknown status
Condition(s):Systemic Sclerosis; Diffuse Sclerosis Systemic; Interstitial Lung Disease; Pulmonary HypertensionLast Updated:September 11, 2023Recruiting
Condition(s):Mitochondrial Diseases; Drug Resistant Epilepsy; Leigh Disease; Leigh Syndrome; Mitochondrial Encephalopathy (MELAS); Pontocerebellar Hypoplasia Type 6 (PCH6); Alpers Disease; Alpers SyndromeLast Updated:March 8, 2024Completed
Condition(s):Relapsing-remitting Multiple SclerosisLast Updated:January 13, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.